Heart Failure Resulting From Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin
Lawreen H. Connors(Boston University), David C. Seldin(Boston University), John L. Berk(Université Paris-Sud), Fangui Sun(Boston University), Flora Sam(Boston University), Francesco Salinaro(University of Pavia), Martha Skinner(Boston University), Frederick L. Ruberg(Boston University)
Cited by 318
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year Study
|Annals of Internal Medicine|2004|615